Ibogaine, a hallucinogen derived from an African plant, is used (illegally) as a cure for opiate addiction. This month, the Multidisciplinary Association for Psychedelic Research will test the effectiveness of Ibogaine on heroin addicts.
Popular Science has a brief article about the upcoming trial.
“As great as ibogaine seems, no one knows exactly how effective it is as a treatment,” says Valerie Mojieko, the director of clinical research for the Multidisciplinary Association for Psychedelic Research (MAPS), a privately funded Massachusetts-based nonprofit. So starting this month, MAPS will enlist Clare Wilkins, the director of Pangea Biomedics, to run the first long-term study to gauge the drug’s lasting effects at her clinic in Mexico (where patients already pay $5,000 for the treatment). She will treat 20 to 30 heroin addicts and, for the next year, MAPS will subject them to psychological and drug tests to quantify ibogaine’s effectiveness.
Fighting Drugs With Drugs: An Obscure Hallucinogen Gains Legitimacy as a Solution for Addictions
No comments:
Post a Comment